Olaparib is already used to treat tumors with BRCA mutations, such as ovarian, breast and prostate cancers. In addition, Olaparib was selective in inhibiting ATM-deficient tumor cells, suggesting that Olaparib could be used as a potential agent for treating ATM-mutated lymphatic tumors.
Product Name | Orapani |
CAS | 763113-22-0 |
Molecular formula | C24H23FN4O3 |
Molecular weight | 434.46 |
Character | white powder |
Density | 1.43 |
Refractive index | 1.70 |